Scientific Literature Search

Source record

Motor fluctuations in levodopa treatment: clinical pharmacology.

Stocchi F, Bonamartini A, Vacca L, Ruggieri S.

Eur Neurol · 1996-01-01

DOI: 10.1159/000118882PMID: 8791020

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Clozapine as a treatment for psychosis in Parkinson's disease: a review.

Musser WS, Akil M.

J Neuropsychiatry Clin Neurosci · 1996-01-01

DOI: 10.1176/jnp.8.1.1PMID: 8845691

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Sustained-release Madopar HBS compared with standard Madopar in the long-term treatment of de novo parkinsonian patients.

Dupont E, Andersen A, Boas J, Boisen E, Borgmann R, Helgetveit AC, Kjaer MO, Kristensen TN, Mikkelsen B, Pakkenberg H, Presthus J, Stien R, Worm-Petersen J, Buch D.

Acta Neurol Scand · 1996-01-01

DOI: 10.1111/j.1600-0404.1996.tb00163.xPMID: 8825266

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study.

Przuntek H, Welzel D, Gerlach M, Blümner E, Danielczyk W, Kaiser HJ, Kraus PH, Letzel H, Riederer P, Uberla K.

J Neural Transm (Vienna) · 1996-01-01

DOI: 10.1007/bf01271230PMID: 8836932

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Sustained-release of levodopa: single dose study of a new formulation.

Gerlach M, Kuhn W, Müller T, Klotz P, Przuntek H.

J Neural Transm (Vienna) · 1996-01-01

DOI: 10.1007/bf01271231PMID: 8836933

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Motor actions of eliprodil in the normal and monoamine-depleted mouse: a role in the treatment of Parkinson's disease?

Brooks S, Kaur S, Starr BS, Starr MS.

J Neural Transm (Vienna) · 1996-01-01

DOI: 10.1007/bf01271233PMID: 8836935

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[The phototherapy of parkinsonism patients].

Artemenko AR, Levin IaI.

Zh Nevrol Psikhiatr Im S S Korsakova · 1996-01-01

PMID: 8992840

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Use of neurotransplantation in the treatment of Parkinson's disease].

Ugriumov MV, Shabalov VA, Fedorova NV, Popov AP, Shtok VN, Sotnikova EI, Melikian AG, Gatina TA, Fetisov SO, Arkhipova NA, Buklina SB, Lutsenko GV.

Vestn Ross Akad Med Nauk · 1996-01-01

PMID: 8963196

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Clozapine for the treatment of psychosis in Parkinson's disease: chart review of 49 patients.

Wagner ML, Defilippi JL, Menza MA, Sage JI.

J Neuropsychiatry Clin Neurosci · 1996-01-01

DOI: 10.1176/jnp.8.3.276PMID: 8854298

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Validation of a rodent model of Parkinson's Disease: evidence of a therapeutic window for oral Sinemet.

Lindner MD, Plone MA, Francis JM, Emerich DF.

Brain Res Bull · 1996-01-01

DOI: 10.1016/0361-9230(96)00027-5PMID: 9138746

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Population pharmacokinetics and pharmacodynamics of oral levodopa in parkinsonian patients.

Triggs EJ, Charles BG, Contin M, Martinelli P, Cortelli P, Riva R, Albani F, Baruzzi A.

Eur J Clin Pharmacol · 1996-01-01

DOI: 10.1007/s002280050161PMID: 8880053

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Plasma HVA and MHPG in psychiatric patients with renal failure and levodopa-treated Parkinson's disease.

Bowers MB.

J Neuropsychiatry Clin Neurosci · 1996-01-01

DOI: 10.1176/jnp.8.4.450PMID: 9116484

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

21.218 articles found

Motor fluctuations in levodopa treatment: clinical pharmacology.

Clozapine as a treatment for psychosis in Parkinson's disease: a review.

Sustained-release Madopar HBS compared with standard Madopar in the long-term treatment of de novo parkinsonian patients.

Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study.

Sustained-release of levodopa: single dose study of a new formulation.

Motor actions of eliprodil in the normal and monoamine-depleted mouse: a role in the treatment of Parkinson's disease?

[The phototherapy of parkinsonism patients].

[Use of neurotransplantation in the treatment of Parkinson's disease].

Clozapine for the treatment of psychosis in Parkinson's disease: chart review of 49 patients.

Validation of a rodent model of Parkinson's Disease: evidence of a therapeutic window for oral Sinemet.

Population pharmacokinetics and pharmacodynamics of oral levodopa in parkinsonian patients.

Plasma HVA and MHPG in psychiatric patients with renal failure and levodopa-treated Parkinson's disease.

Filters